Research shows RSV leads to high hospitalization rates in adults, emphasizing the importance of enhanced surveillance and ...

Health Secretary Robert F. Kennedy Jr. endorsed the expanded use of RSV vaccines for people 50 through 59 years old who are ...

A second monoclonal antibody to prevent respiratory syncytial virus (RSV) in infants has been recommended by the CDC’s Advisory Committee on Immunization Practices (ACIP). Five members voted yes ...

The Trump administration appears to be expanding RSV vaccinations to some adults starting at age 50 instead of 60. Health ...

Levels of the COVID virus predicted case counts by about a week in the Twin Cities region of Minnesota COVID appears to ...

RSV seasons ended earlier than usual in 2022-23 and 2023-24, and typical human hMPV circulation patterns have returned since the COVID-19 pandemic.

A U.S. government scientist who oversees the team responsible for collecting data on COVID-19 and RSV hospitalizations used to shape national vaccine policy has resigned, citing concerns over how ...

Gilead Sciences has blamed the low rate of respiratory syncytial virus (RSV) infections last season for ending two midstage ...

A U.S. government scientist who oversees the team responsible for collecting data on COVID-19 and RSV hospitalizations used to shape national vaccine policy has resigned, citing concerns over how such ...

ABC News contributor Dr. Alok Patel talks about the rise of illnesses like COVID-19, RSV and the flu during the winter months and what you can do to protect yourself.

This resource details recent developments in vaccinations, how addressing misinformation and hesitancy can improve public health, updated vaccination guidelines and more.